3
Total investments
2
Early stage
1
Mid stage
0
Late stage
10y
Years active
Portfolio
3 investments Β· sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor/Co-Founder
Mar 2017
DeepAffects is a cloud-based conversation intelligence platform driven by AI, for the enterprise to quickly integrate secure, scalable & highly accurate speaker identification, diarization, emotion recognition, and speech enhancement into the voice products. Led by a team of Artificial Intelligence & Signal processing researchers, DeepAffects is democratizing core AI technologies which enable the expanding voice economy.
Investor
Apr 2016
ExtraaEdge is a data science-driven Sales and Marketing software developed for Educational Institutes. Focused on increasing student enrollments and optimizing the marketing cost via automation and analytics.
ExtraaEdge is an early start-up founded in 2016, currently powering 350+ Educational Institutes with the cloud computing solution. Founded by Abhishek Ballabh (ex. HSBC Data Scientist) & Sushil Mundada (ex. HSBC - Lead BA & CRM Architect) ExtraaEdge delivers all the required tools for End-to-End automation of admissions processes. With their combined passion for education and knowledge expertise in Data and CRM, they contribute by developing ExtraaEdge.
What is the purpose of ExtraaEdge?
It enables educational institutes to automate, streamline and manage their student enrollment funnel. Also through behaviour analytics, institutes can measure their ROI during the critical admission period. Take course corrective measures, optimize efforts to the granular level and much more. Overall increasing admissions and reducing the marketing spend for Educational Institutes.
Benefits of having our Admissions and Marketing Automation Software for any Education Setup are as follows:
1. Increase your Marketing Return On Investment
2. Optimize the efficiency of the Counselling team
3. Accelerate Admissions with Marketing & Admissions Automation
4. Track your end to end marketing and admissions activity to perform better year on year
Bouquet of Tools & Technology;
Predictive Analytics
Lead Management System / CRM
Mobile CRM
Marketing Automation
In-built communication Channels
Online Application Form solutions
Chat solutions for Website - Chatbot, Live Chat
Application forms
Payment Solutions
End-to-End Reports & Analytics
To know more visit - http://www.extraaedge.com
Experience Β· 8 entries
All (8)
Investments (2)
Founder (5)
2023
Head of Artificial Intelligence / CTO (Advisor)
Dec 2023
ThinkingNodeLife.ai (TNL) is the first AI Digital Cells Lab that can generate mechanistic digital human cell clones within a few hours using -omics data. This allows the prediction and the understanding of the impacts of molecules or drugs on any human cells of interest. By being able to mechanistically identify novel disease-targets and to simulate each drug in various R&D phases, TNL provides a decisive advantage for developing both first-in-class and best-in-class drugs. This impacts the entire drug R&D value chain in multiple ways.
For example, all assets of a pharmaceutical company can be prioritized for early development and existing launched products can be quickly repurposed for new indications. The TNL AI Digital Cells Lab has already proven its effectiveness in serving biopharmaceutical customers, particularly in the realms of cancer and autoimmune diseases.
All this is possible based on its novel Generative Distributed Reasoning AI (GDR-AI) that employs Distributed Reasoning AI instead of statistical correlation to generate causal reasoning models.
Khai Pham, MD & PhD (AI) (Sorbonne University), is the founder & CEO of TNL. He has been in the AI field for 30 years. Few have worked on unifying AI across different approaches (Machine Learning, Reasoning AI, and Distributed Multi-Agent AI). He is the leading expert in Distributed AI. The first generation of his Distributed AI was used in his first AI company (acq. by Nasdaq: EPNY for $637M). At TNL, he is surrounded by an amazing multi-disciplinary executive team that has been involved in $10+B total exits.
2020
Founder
Aug 2020
At Healiom, we believe everyone should have positive care experiences and everything we do is to ensure that positive care experience is accessible to everyone.
Healiom is an AI-based real-time specialist care logistics platform that enables access to real-time medical specialist care for mid-level acuity conditions and chronic condition risk assessment. Timely access to specialist care ultimately improves quality, risk scores and healthcare economics.
The holistic design of the platform offers longitudinal data access and immediate payments to providers, meets regulatory and billing requirements, and elevates healthcare standards by instituting QA.
2018
C
Connected Care Health Services
Board Member, Advisor, Strategy, Founder, Health Plan
Nov 2018
Co-Founder, Chief Technology Officer & Chief Data Scientist
May 2018
WithMe Health is an innovative Pharmacy Benefit Manager (PBM) that puts members at the center of their healthcare experience. When members are engaged, everybody wins - leading to improved outcomes, lower cost of care, and reduced administrative burden for members, plan sponsors, and providers. Through WithMes clinically driven mPath360 technology and empathy-led medication guides, WithMe creates a truly personalized medication experience that connects the dots across the care spectrum.
Our mission is to create a significantly better medication experience for all our members, putting their health and needs first as they navigate the complexity of medications by offering our clinical expertise to them and their trusted providers to save them money and to improve their health.
Our pharmacist and pharma-tech Medication Guides are available to members 24/7 to provide medication counseling and guidance via our easy-to-use member app, live chat, and over the phone.
To date, weβve raised over $40 million from Oak HC/FT, OMERS Ventures, and other leading healthcare VCs and strategic partners to take on the $450+ billion PBM industry.
2017
Show all 8 entries β
Investment activity
2016β2017 Β· 3 investments
Recent (last 2 years)Earlier
